+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global In Vitro Diagnostics (IVD) Quality Control Market, by Source (Plasma, Whole Blood, Urine), Technology (Immunoassay, Hematology, Microbiology, Molecular Diagnostics), Manufacturer (Third-party, OEM), End Users (Hospitals, Lab) - Forecast to 2026

  • ID: 5438186
  • Report
  • September 2021
  • Region: Global
  • 333 Pages
  • Markets and Markets
Market Projected to Reach USD 1.4 Billion by 2026 from USD 1.1 Billion in 2021, at a CAGR of 5.3%

FEATURED COMPANIES

  • Abbott Laboratories
  • Danaher Corporation
  • LGC Limited
  • Qnostics
  • Roche Diagnostics
  • Siemens Healthineers

The global IVD quality control market is projected to reach USD 1.4 billion by 2026 from USD 1.1 billion in 2021, at a CAGR of 5.3% during the forecast period. IVD testing plays a significant role in clinical decision-making.



The growth of the IVD quality control market is primarily driven by the rising number of accredited clinical laboratories, rising geriatric population, rising demand for external quality assessment programs, increasing adoption of and POC instruments in developed regions and increasing adoption of third-party quality controls.

The rising focus on multi-analyte controls is also expected to offer significant growth opportunities for the market in the coming years. The use of quality control products is, however, not mandatory for all clinical laboratories in many countries. The lack of regulations for these products is expected to adversely affect market growth.

The product & service segment holds the highest share of the total IVD quality control market during the forecast period

Based on product & service, the IVD quality control market is segmented into quality control products, data management solutions, and quality assurance services. The quality control products segment accounted for the largest share of the IVD quality control market in 2020.

The increasing number of accredited laboratories and mandates for the use of quality controls from regulatory bodies to ensure the accuracy of diagnostic test results are driving the growth of the IVD quality control products market.

Serum based controls drive the growth of the quality control products segment during the forecast period

Based on type, the IVD quality control products market is segmented into serum/plasma-based controls, whole blood-based controls, urine-based controls, and others. Serum/plasma-based controls are highly preferred by laboratories; this segment accounted for the largest share of the quality control products market in 2020.

The greater uptake of serum/plasma-based quality controls among laboratories and the wide application areas of these controls for various IVD tests are driving the market growth.

Molecular diagnostics segment accounted for the highest CAGR of the global IVD quality control market

Based on technology, the IVD quality control market is broadly segmented into clinical chemistry, immunochemistry, hematology, coagulation & hemostasis, microbiology, molecular diagnostics, and other technologies. The molecular diagnostics segment has the highest CAGR for the forecast period.

With the increased non-communicable disease burden, molecular diagnostic tests have been used in the field of oncology widely. Technological advancement in the field of molecular diagnostics is another driver for the growth of this industry.

Third-party controls accounted for the highest share for the IVD quality control market

Based on manufacturer, the IVD quality control market is segmented into third-party controls and OEM controls. The third-party controls segment accounted for the largest share of the global IVD quality control market in 2020.

The large share of this segment can be attributed to the increasing use of third-party quality controls across the globe to verify the accuracy and reliability of tests.

Based on end users, hospitals accounted for the highest share of the global IVD quality control market during the forecast period

The key end users of IVD quality controls studied in this report include hospitals, clinical laboratories, research & academic institutes, and other end users. The hospitals segment accounted for the largest share of the IVD quality control market in 2020, owing to the large volume of diagnostic tests carried out in hospitals.

North America is expected to account for the highest share for players operating in the global IVD quality control market

Geographically, the global IVD quality control market studied in this report is divided into five major regions-North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the global IVD quality control market, followed by Europe.

The APAC region has the highest CAGR of the global IVD quality control market. The Asia Pacific is considered the most lucrative market for IVD quality controls, owing to the region’s large patient population and rising healthcare needs.

Market players are focusing on improving laboratory test quality in emerging APAC countries by working with local government bodies, agencies, and academic societies to offer external QC for standardizing laboratory testing procedures and ensure accuracy.

Breakup of primary participants:

  • By Company Type: Tier 1 - 60%, Tier 2 - 30%, and Tier 3 - 10%
  • By Designation: C-level - 30%, Director-level - 50%, Others - 20%
  • By Region: North America - 45%, Europe - 15%, Asia Pacific - 25%, Latin America - 10%, Middle East and Africa - 5%

Key players in the IVD quality control Market

Some of the key players in the market include Bio-Rad Laboratories, Inc. (US), Randox Laboratories Ltd. (UK), Thermo Fisher Scientific, Inc. (US), LGC Limited (UK), and Abbott Laboratories (US). Other prominent payers in the market include Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Fortress Diagnostics (UK), SERO AS (US), Sysmex Corporation (Japan), Ortho-Clinical Diagnostics (US), Helena Laboratories Corporation (US), Quidel Corporation (US), Sun Diagnostics, LLC (US), Seegene Inc. (South Korea), ZeptoMetrix Corporation (US), Qnostics (UK), Bio-Techne Corporation (US), Microbiologics (US), Microbix Biosystems (Canada), Streck, Inc. (US), Alpha-Tec Systems (US), Maine Molecular Quality Controls, Inc. (US), and Grifols, S.A. (Spain).

These players aim to secure higher market shares through strategies such as product launches, expansions, agreements, and acquisitions.

Research Coverage:

The report analyzes the IVD quality control market and aims at estimating the market size and future growth potential of this market based on various segments such as product, technology, manufacturer type, end user, and region.

The report also includes a product portfolio matrix of various IVD quality control available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global IVD quality control market. The report analyzes this market by product, technology, manufacturer type, end user, and region.
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global IVD quality control market
  • Market Development: Comprehensive information on the lucrative emerging markets by product, technology, manufacturer type, end user, and region.
  • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global IVD quality control market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global IVD quality control market.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Danaher Corporation
  • LGC Limited
  • Qnostics
  • Roche Diagnostics
  • Siemens Healthineers

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Inclusions & Exclusions of the Study
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.3.3 Currency
Table 1 Exchange Rates Utilized for Conversion To USD
1.4 Stakeholders
1.5 Summary of Changes

2 Research Methodology
2.1 Research Data
Figure 1 Research Design
2.1.1 Secondary Data
2.1.1.1 Key data from secondary sources
2.1.2 Primary Data
Figure 2 Primary Sources
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Breakdown of Primary Interviews: Supply-Side and Demand- Side Participants
2.2 Market Size Estimation
Figure 5 Supply-Side Market Size Estimation: Revenue Share Analysis
Figure 6 Revenue Share Analysis Illustration: Bio-Rad Laboratories, Inc.
Figure 7 Revenue Analysis of the Top Five Companies: IVD Quality Control Market (2020)
Figure 8 CAGR Projections From the Analysis of Drivers, Restraints, Opportunities, and Challenges of the IVD Quality Control Market (2021-2026)
Figure 9 CAGR Projections
Figure 10 Top-Down Approach
2.3 Market Breakdown & Data Triangulation
Figure 11 Market Data Triangulation Methodology
2.4 Market Share Analysis
2.5 Assumptions for the Study
2.6 Risk Assessment
Table 2 Risk Assessment: IVD Quality Control Market
2.7 Limitations
2.7.1 Methodology-Related Limitations
2.7.2 Scope-Related Limitations

3 Executive Summary
Figure 12 IVD Quality Control Market, by Product & Service, 2021 Vs. 2026 (USD Million)
Figure 13 IVD Quality Control Products Market, by Type, 2021 Vs. 2026 (USD Million)
Figure 14 IVD Quality Control Market, by Manufacturer, 2021 Vs. 2026 (USD Million)
Figure 15 Third-Party Controls Market, by Type, 2021 Vs. 2026 (USD Million)
Figure 16 IVD Quality Control Market, by Technology, 2021 Vs. 2026 (USD Million)
Figure 17 IVD Quality Control Market, by End User, 2021 Vs. 2026 (USD Million)
Figure 18 IVD Quality Control Market: Geographic Snapshot

4 Premium Insights
4.1 IVD Quality Control Market Overview
Figure 19 Growing Adoption of Third-Party Controls and Increasing Demand for External Quality Assessment To Drive Market Growth
4.2 APAC: IVD Quality Control Market, by Technology and Country (2020)
Figure 20 Immunochemistry To Command the Largest Share of the APAC IVD Quality Control Market In 2020
4.3 IVD Quality Control Market: Geographic Mix
Figure 21 China To Grow At the Highest CAGR During the forecast Period
4.4 IVD Quality Control Market: Developed vs Developing Markets
Figure 22 Developing Markets To Register Highest CAGR During the forecast Period

5 Market Overview
5.1 Market Dynamics
Figure 23 IVD Quality Control Market: Drivers, Restraints, Opportunities, and Challenges
5.1.1 Market Drivers
5.1.1.1 Increasing number of accredited clinical laboratories
Figure 24 US: Number of Laboratories With Clia Accreditation, by Organization (2018)
5.1.1.2 Growing adoption of third-party quality controls
5.1.1.3 Rising demand for external quality assessment support
5.1.1.4 Rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases
Table 3 Estimated Increase In the Geriatric Population, by Region (2019-2050)
Figure 25 Estimated Diabetic Population, by Region, 2019 Vs. 2030 Vs. 2040
Figure 26 Global Cancer Incidence, 2015-2040
5.1.1.5 Increasing adoption of Poc instruments in developed regions
Table 4 Market Drivers: Impact Analysis
5.1.2 Market Restraints
5.1.2.1 Additional costs and budget constraints in hospitals and laboratories
5.1.2.2 Unfavorable reimbursement scenario for IVD tests
Table 5 Market Restraints: Impact Analysis
5.1.3 Market Opportunities
5.1.3.1 Rising demand for multi-analyte controls
Table 6 Market Opportunities: Impact Analysis
5.1.4 Market Challenges
5.1.4.1 Stringent product approval process
5.1.4.2 Lack of regulations for clinical laboratory accreditation in several emerging countries
Table 7 Market Challenges: Impact Analysis
5.2 Industry Trends
5.2.1 Lyophilized/Freeze-Dried Controls
Table 8 Lyophilized Or Freeze-Dried Quality Controls offered by Key Market Players
5.2.2 Trends On Analyte Source: Human Vs. Animal Origin
5.2.3 Consolidation of Laboratories
5.3 Value Chain Analysis
Figure 27 IVD Quality Control Market: Value Chain Analysis
5.4 Supply Chain Analysis
Figure 28 IVD Quality Control Market: Supply Chain Analysis
5.5 Ecosystem Market Map
Figure 29 IVD Quality Control Market: Ecosystem Market Map
5.6 Porter’S Five forces Analysis
5.6.1 Threat From New Entrants
5.6.2 Threat From Substitutes
5.6.3 Bargaining Power of Suppliers
5.6.4 Bargaining Power of Buyers
5.6.5 Intensity of Competitive Rivalry
5.7 Regulatory Analysis
5.7.1 North America
5.7.1.1 US
Table 9 US: Classification of Quality Control Material
Table 10 US: Time, Cost, and Complexity of Registration
5.7.1.2 Canada
Table 11 Canada: Classification of IVD Products
Table 12 Canada: Time, Cost, and Complexity of Registration
5.7.2 Europe
Table 13 Europe: Accreditation Bodies for Medical Laboratories
Table 14 Europe: Time, Cost, and Complexity of Registration
5.7.3 Asia Pacific
5.7.3.1 Japan
Table 15 Japan: Time, Cost, and Complexity of Registration
5.7.3.2 China
Table 16 China: Time, Cost, and Complexity of Registration
5.7.3.3 India
Table 17 India: Time, Cost, and Complexity of Registration
5.8 Impact of COVID-19 On the IVD Quality Control Market
Figure 30 Thermo Fisher Scientific Inc.: COVID-19 Impact On Segmental Analysis
Figure 31 Roche Diagnostics.: COVID-19 Impact On Segmental Analysis
Figure 32 Bio-Rad Laboratories, Inc.: COVID-19 Impact On Segmental Analysis
Figure 33 Abbott Laboratories: COVID-19 Impact On Segmental Analysis
5.9 Patent Analysis
5.9.1 Patent Publication Trends for IVD Quality Controls
Figure 34 Patent Publication Trends (2011-August 2021)
5.9.2 Insights: Jurisdiction and Top Applicant Analysis
Figure 35 Top Applicants and Owners (Companies/Institutions) For IVD Quality Control Patents (January 2011-August 2021)
Figure 36 Top Applicant Countries/Regions for IVD Quality Control Patents (January 2011-August 2021)
5.10 Technology Analysis
5.10.1 Key Technologies
5.10.1.1 Analyte extraction
5.10.1.1.1 Specimen pooling
5.10.1.1.2 Human monoclonals
5.10.1.2 Specimen processing
5.10.1.2.1 Inactivation
5.10.1.2.2 Dilution
5.10.1.3 Preservation
5.10.2 Adjacent Technologies
5.10.2.1 Sensor-based quality control
5.10.3 Complementary Technologies
5.10.3.1 Storage
5.10.3.2 Transport
5.10.3.3 Temperature control
5.10.3.4 Temperature monitoring

6 IVD Quality Control Market, by Product and Service
6.1 Introduction
Table 18 IVD Quality Control Market, by Product & Service, 2019-2026 (USD Million)
6.2 Quality Control Products
Table 19 Quality Control Products Market, by Type, 2019-2026 (USD Million)
Table 20 Quality Control Products Market, by Country, 2019-2026 (USD Million)
6.2.1 Serum/Plasma-Based Controls
6.2.1.1 Greater stability and accuracy of diagnostic test results to increase the demand for serum/plasma-based controls
Table 21 Serum/Plasma-Based Quality Controls offered by Key Market Players
Table 22 Serum/Plasma-Based Quality Control Products Market, by Country, 2019-2026 (USD Million)
6.2.2 Whole Blood-Based Controls
6.2.2.1 Rising need to ensure high-quality clinical test results to drive the whole blood-based controls market
Table 23 Whole Blood-Based Quality Controls offered by Key Market Players
Table 24 Whole Blood-Based Quality Control Products Market, by Country, 2019-2026 (USD Million)
6.2.3 Urine-Based Controls
6.2.3.1 The growing incidence of kidney diseases increase the need for urine-based controls
Table 25 Urine-Based IVD Controls offered by Key Market Players
Table 26 Urine-Based Quality Control Products Market, by Country, 2019-2026 (USD Million)
6.2.4 Other Controls
Table 27 Other Controls offered by Key Market Players
Table 28 Other Quality Control Products Market, by Country, 2019-2026 (USD Million)
6.3 Data Management Solutions
6.3.1 Rising Focus On Improving the Analytical Performance of Clinical Laboratories To Support Market Growth
Table 29 Data Management Solutions offered by Key Market Players
Table 30 Data Management Solutions Market, by Country, 2019-2026 (USD Million)
6.4 Quality Assurance Services
6.4.1 Growing Need for Performance Assessment of Clinical Laboratories To Increase the Demand for Quality Assurance Services
Table 31 Quality Assurance Services offered by Key Market Players
Table 32 Quality Assurance Services Market, by Country, 2019-2026 (USD Million)

7 IVD Quality Control Market, by Technology
7.1 Introduction
Table 33 IVD Quality Control Market, by Technology, 2019-2026 (USD Million)
7.2 Immunochemistry
7.2.1 Focus On Monitoring the Precision of Immunoassay Tests To Drive the Adoption of Immunoassay Controls
Table 34 Quality Controls for Immunochemistry offered by Key Market Players
Table 35 IVD Quality Control Market for Immunochemistry, by Country, 2019-2026 (USD Million)
7.3 Clinical Chemistry
7.3.1 Rising Incidence of Lifestyle Diseases To Provide Opportunities for Market Growth
Table 36 Quality Controls for Clinical Chemistry offered by Key Market Players
Table 37 IVD Quality Control Market for Clinical Chemistry, by Country, 2019-2026 (USD Million)
7.4 Molecular Diagnostics
7.4.1 Growing Incidence of Infectious Diseases To Drive the Demand for Molecular Diagnostic Controls
Table 38 Quality Controls for Molecular Diagnostics offered by Key Market Players
Table 39 IVD Quality Control Market for Molecular Diagnostics, by Country, 2019-2026 (USD Million)
7.5 Microbiology
7.5.1 Increasing Adoption of Automated Clinical Microbiology Testing Instruments To Support Market Growth
Table 40 Quality Controls for Microbiology offered by Key Market Players
Table 41 IVD Quality Control Market for Microbiology, by Country, 2019-2026 (USD Million)
7.6 Hematology
7.6.1 Need for Accuracy In Hematological Test Results To Drive Reliance On Hematology Quality Controls
Table 42 Quality Controls for Hematology offered by Key Market Players
Table 43 IVD Quality Control Market for Hematology, by Country, 2019-2026 (USD Million)
7.7 Coagulation & Hemostasis
7.7.1 Growing Number of Cardiovascular Surgeries To Drive the Need for Coagulation & Hemostasis Testing
Table 44 Quality Controls for Coagulation & Hemostasis offered by Key Market Players
Table 45 IVD Quality Control Market for Coagulation & Hemostasis, by Country, 2019-2026 (USD Million)
7.8 Other Technologies
Table 46 Quality Controls for Other Technologies offered by Key Market Players
Table 47 IVD Quality Control Market for Other Technologies, by Country, 2019-2026 (USD Million)

8 IVD Quality Control Market, by Manufacturer
8.1 Introduction
Table 48 IVD Quality Control Market, by Manufacturer, 2019-2026 (USD Million)
8.2 Third-Party Controls
Table 49 Third-Party Controls Market, by Type, 2019-2026 (USD Million)
Table 50 Third-Party Controls Market, by Country, 2019-2026 (USD Million)
8.2.1 Independent Controls
8.2.1.1 Increased preference for independent controls to fuel market growth
Table 51 Independent Controls offered by Key Market Players
Table 52 Independent Third-Party Controls Market, by Country, 2019-2026 (USD Million)
8.2.2 Instrument-Specific Controls
8.2.2.1 Usage limitations to subdue market growth rate in favor of independent controls
Table 53 Instrument-Specific Controls offered by Key Market Players
Table 54 Instrument-Specific Third-Party Controls Market, by Country, 2019-2026 (USD Million)
8.3 Original Equipment Manufacturer Controls
8.3.1 OEM Controls To Witness Lower Adoption As they Are Less Sensitive To Qc-Related Issues
Table 55 OEM Controls offered by Key Market Players
Table 56 Original Equipment Manufacturer Controls Market, by Country, 2019-2026 (USD Million)

9 IVD Quality Control Market, by End User
9.1 Introduction
Table 57 IVD Quality Control Market, by End User, 2019-2026 (USD Million)
9.2 Hospitals
9.2.1 Huge Volume of IVD Procedures Performed In Hospitals To Drive Market Growth
Table 58 IVD Quality Control Market for Hospitals, by Country, 2019-2026 (USD Million)
9.3 Clinical Laboratories
9.3.1 Growing Number of Accredited Laboratories To Drive the Market
Table 59 IVD Quality Control Market for Clinical Laboratories, by Country, 2019-2026 (USD Million)
9.4 Academic and Research Institutes
9.4.1 Rising Focus On Accurate Research Results To Drive Market Growth
Table 60 IVD Quality Control Market for Academic and Research Institutes, by Country, 2019-2026 (USD Million)
9.5 Other End Users
Table 61 IVD Quality Control Market for Other End Users, by Country, 2019-2026 (USD Million)

10 IVD Quality Control Market, by Region
10.1 Introduction
Table 62 IVD Quality Control Market, by Region, 2019-2026 (USD Million)
Table 63 IVD Quality Control Market, by Country, 2019-2026 (USD Million)
10.2 North America
Figure 37 North America: IVD Quality Control Market Snapshot
Table 64 North America: IVD Quality Control Market, by Country, 2019-2026 (USD Million)
Table 65 North America: IVD Quality Control Market, by Product & Service, 2019-2026 (USD Million)
Table 66 North America: IVD Quality Control Products Market, by Type, 2019-2026 (USD Million)
Table 67 North America: IVD Quality Control Market, by Technology, 2019-2026 (USD Million)
Table 68 North America: IVD Quality Control Market, by Manufacturer, 2019-2026 (USD Million)
Table 69 North America: Third-Party Controls Market, by Type, 2019-2026 (USD Million)
Table 70 North America: IVD Quality Control Market, by End User, 2019-2026 (USD Million)
10.2.1 US
10.2.1.1 High healthcare expenditure in the country and the implementation of mandatory laboratory accreditation and quality assurance guidelines in laboratories to drive market growth in the US
Table 71 US: Key Macroindicators
Table 72 US: IVD Quality Control Market, by Product & Service, 2019-2026 (USD Million)
Table 73 US: IVD Quality Control Products Market, by Type, 2019-2026 (USD Million)
Table 74 US: IVD Quality Control Market, by Technology, 2019-2026 (USD Million)
Table 75 US: IVD Quality Control Market, by Manufacturer, 2019-2026 (USD Million)
Table 76 US: Third-Party Controls Market, by Type, 2019-2026 (USD Million)
Table 77 US: IVD Quality Control Market, by End User, 2019-2026 (USD Million)
10.2.2 Canada
10.2.2.1 Government initiatives to promote quality controls to drive market growth in Canada
Table 78 Canada: Key Macroindicators
Table 79 Canada: IVD Quality Control Market, by Product & Service, 2019-2026 (USD Million)
Table 80 Canada: IVD Quality Control Products Market, by Type, 2019-2026 (USD Million)
Table 81 Canada: IVD Quality Control Market, by Technology, 2019-2026 (USD Million)
Table 82 Canada: IVD Quality Control Market, by Manufacturer, 2019-2026 (USD Million)
Table 83 Canada: Third-Party Controls Market, by Type, 2019-2026 (USD Million)
Table 84 Canada: IVD Quality Control Market, by End User, 2019-2026 (USD Million)
10.3 Europe
Table 85 Europe: IVD Quality Control Market, by Country, 2019-2026 (USD Million)
Table 86 Europe: IVD Quality Control Market, by Product & Service, 2019-2026 (USD Million)
Table 87 Europe: IVD Quality Control Products Market, by Type, 2019-2026 (USD Million)
Table 88 Europe: IVD Quality Control Market, by Technology, 2019-2026 (USD Million)
Table 89 Europe: IVD Quality Control Market, by Manufacturer, 2019-2026 (USD Million)
Table 90 Europe: Third-Party Controls Market, by Type, 2019-2026 (USD Million)
Table 91 Europe: IVD Quality Control Market, by End User, 2019-2026 (USD Million)
10.3.1 Germany
10.3.1.1 Increasing number of certified laboratories and the rising volume of high-quality tests performed by these laboratories to support market growth in Germany
Table 92 Germany: Key Macroindicators
Table 93 Germany: IVD Quality Control Market, by Product & Service, 2019-2026 (USD Million)
Table 94 Germany: IVD Quality Control Products Market, by Type, 2019-2026 (USD Million)
Table 95 Germany: IVD Quality Control Market, by Technology, 2019-2026 (USD Million)
Table 96 Germany: IVD Quality Control Market, by Manufacturer, 2019-2026 (USD Million)
Table 97 Germany: Third-Party Controls Market, by Type, 2019-2026 (USD Million)
Table 98 Germany: IVD Quality Control Market, by End User, 2019-2026 (USD Million)
10.3.2 France
10.3.2.1 Increasing prevalence of infectious diseases and growing demand for early diagnosis to drive market growth
Table 99 France: Key Macroindicators
Table 100 France: IVD Quality Control Market, by Product & Service, 2019-2026 (USD Million)
Table 101 France: IVD Quality Control Products Market, by Type, 2019-2026 (USD Million)
Table 102 France: IVD Quality Control Market, by Technology, 2019-2026 (USD Million)
Table 103 France: IVD Quality Control Market, by Manufacturer, 2019-2026 (USD Million)
Table 104 France: Third-Party Controls Market, by Type, 2019-2026 (USD Million)
Table 105 France: IVD Quality Control Market, by End User, 2019-2026 (USD Million)
10.3.3 UK
10.3.3.1 Growth in the life science industry and increased research to drive market growth in the UK
Table 106 UK: Key Macroindicators
Table 107 UK: IVD Quality Control Market, by Product & Service, 2019-2026 (USD Million)
Table 108 UK: IVD Quality Control Products Market, by Type, 2019-2026 (USD Million)
Table 109 UK: IVD Quality Control Market, by Technology, 2019-2026 (USD Million)
Table 110 UK: IVD Quality Control Market, by Manufacturer, 2019-2026 (USD Million)
Table 111 UK: Third-Party Controls Market, by Type, 2019-2026 (USD Million)
Table 112 UK: IVD Quality Control Market, by End User, 2019-2026 (USD Million)
10.3.4 Italy
10.3.4.1 Growing disease prevalence to drive the demand for better and more accurate disease diagnosis in Italy
Table 113 Italy: Key Macroindicators
Table 114 Italy: IVD Quality Control Market, by Product & Service, 2019-2026 (USD Million)
Table 115 Italy: IVD Quality Control Products Market, by Type, 2019-2026 (USD Million)
Table 116 Italy: IVD Quality Control Market, by Technology, 2019-2026 (USD Million)
Table 117 Italy: IVD Quality Control Market, by Manufacturer, 2019-2026 (USD Million)
Table 118 Italy: Third-Party Controls Market, by Type, 2019-2026 (USD Million)
Table 119 Italy: IVD Quality Control Market, by End User, 2019-2026 (USD Million)
10.3.5 Spain
10.3.5.1 Increasing demand for prenatal and genetic testing and rising focus on laboratory consolidation to support market growth in Spain
Table 120 Spain: Key Macroindicators
Table 121 Spain: IVD Quality Control Market, by Product & Service, 2019-2026 (USD Million)
Table 122 Spain: IVD Quality Control Products Market, by Type, 2019-2026 (USD Million)
Table 123 Spain: IVD Quality Control Market, by Technology, 2019-2026 (USD Million)
Table 124 Spain: IVD Quality Control Market, by Manufacturer, 2019-2026 (USD Million)
Table 125 Spain: Third-Party Controls Market, by Type, 2019-2026 (USD Million)
Table 126 Spain: IVD Quality Control Market, by End User, 2019-2026 (USD Million)
10.3.6 Russia
10.3.6.1 Increasing access to quality healthcare and growing incidence of lifestyle and infectious diseases to drive market growth in Russia
Table 127 Russia: Key Macro Indicators
Table 128 Russia: IVD Quality Control Market, by Product & Service, 2019-2026 (USD Million)
Table 129 Russia: IVD Quality Control Products Market, by Type, 2019-2026 (USD Million)
Table 130 Russia: IVD Quality Control Market, by Technology, 2019-2026 (USD Million)
Table 131 Russia: IVD Quality Control Market, by Manufacturer, 2019-2026 (USD Million)
Table 132 Russia: Third-Party Controls Market, by Type, 2019-2026 (USD Million)
Table 133 Russia: IVD Quality Control Market, by End User, 2019-2026 (USD Million)
10.3.7 Rest of Europe
Table 134 RoE: IVD Quality Control Market, by Product & Service, 2019-2026 (USD Million)
Table 135 RoE: IVD Quality Control Products Market, by Type, 2019-2026 (USD Million)
Table 136 RoE: IVD Quality Control Market, by Technology, 2019-2026 (USD Million)
Table 137 RoE: IVD Quality Control Market, by Manufacturer, 2019-2026 (USD Million)
Table 138 RoE: Third-Party Controls Market, by Type, 2019-2026 (USD Million)
Table 139 RoE: IVD Quality Control Market, by End User, 2019-2026 (USD Million)
10.4 Asia Pacific
Figure 38 Asia Pacific: IVD Quality Control Market Snapshot
Table 140 Asia Pacific: IVD Quality Control Market, by Country, 2019-2026 (USD Million)
Table 141 Asia Pacific: IVD Quality Control Market, by Product & Service, 2019-2026 (USD Million)
Table 142 Asia Pacific: IVD Quality Control Products Market, by Type, 2019-2026 (USD Million)
Table 143 Asia Pacific: IVD Quality Control Market, by Technology, 2019-2026 (USD Million)
Table 144 Asia Pacific: IVD Quality Control Market, by Manufacturer, 2019-2026 (USD Million)
Table 145 Asia Pacific: Third-Party Controls Market, by Type, 2019-2026 (USD Million)
Table 146 Asia Pacific: IVD Quality Control Market, by End User, 2019-2026 (USD Million)
10.4.1 Japan
10.4.1.1 Well-developed healthcare system and the rising demand for improvements in the quality of IVD test results to drive market growth in Japan
Table 147 Japan: Key Macroindicators
Table 148 Japan: IVD Quality Control Market, by Product & Service, 2019-2026 (USD Million)
Table 149 Japan: IVD Quality Control Products Market, by Type, 2019-2026 (USD Million)
Table 150 Japan: IVD Quality Control Market, by Technology, 2019-2026 (USD Million)
Table 151 Japan: IVD Quality Control Market, by Manufacturer, 2019-2026 (USD Million)
Table 152 Japan: Third-Party Controls Market, by Type, 2019-2026 (USD Million)
Table 153 Japan: IVD Quality Control Market, by End User, 2019-2026 (USD Million)
10.4.2 China
10.4.2.1 Growing access to modern healthcare and government support to boost the market growth in China
Table 154 China: Key Macroindicators
Table 155 China: IVD Quality Control Market, by Product & Service, 2019-2026 (USD Million)
Table 156 China: IVD Quality Control Products Market, by Type, 2019-2026 (USD Million)
Table 157 China: IVD Quality Control Market, by Technology, 2019-2026 (USD Million)
Table 158 China: IVD Quality Control Market, by Manufacturer, 2019-2026 (USD Million)
Table 159 China: Third-Party Controls Market, by Type, 2019-2026 (USD Million)
Table 160 China: IVD Quality Control Market, by End User, 2019-2026 (USD Million)
10.4.3 India
10.4.3.1 Rising need to secure NABL accreditations to drive the demand for quality controls in India
Figure 39 India: Increasing Number of Labs With NABL Accreditations, 2012-2020
Table 161 India: Key Macroindicators
Table 162 India: IVD Quality Control Market, by Product & Service, 2019-2026 (USD Million)
Table 163 India: IVD Quality Control Products Market, by Type, 2019-2026 (USD Million)
Table 164 India: IVD Quality Control Market, by Technology, 2019-2026 (USD Million)
Table 165 India: IVD Quality Control Market, by Manufacturer, 2019-2026 (USD Million)
Table 166 India: Third-Party Controls Market, by Type, 2019-2026 (USD Million)
Table 167 India: IVD Quality Control Market, by End User, 2019-2026 (USD Million)
10.4.4 Australia
10.4.4.1 Growing geriatric population has resulted in initiatives to enhance access to healthcare and improve infrastructure
Table 168 Australia: Key Macroindicators
Table 169 Australia: IVD Quality Control Market, by Product & Service, 2019-2026 (USD Million)
Table 170 Australia: IVD Quality Control Products Market, by Type, 2019-2026 (USD Million)
Table 171 Australia: IVD Quality Control Market, by Technology, 2019-2026 (USD Million)
Table 172 Australia: IVD Quality Control Market, by Manufacturer, 2019-2026 (USD Million)
Table 173 Australia: Third-Party Controls Market, by Type, 2019-2026 (USD Million)
Table 174 Australia: IVD Quality Control Market, by End User, 2019-2026 (USD Million)
10.4.5 South Korea
10.4.5.1 Rising healthcare expenditure and the growing number of hospitals to drive the growth of the South Korean market
Table 175 South Korea: Key Macroindicators
Table 176 South Korea: IVD Quality Control Market, by Product & Service, 2019-2026 (USD Million)
Table 177 South Korea: IVD Quality Control Products Market, by Type, 2019-2026 (USD Million)
Table 178 South Korea: IVD Quality Control Market, by Technology, 2019-2026 (USD Million)
Table 179 South Korea: IVD Quality Control Market, by Manufacturer, 2019-2026 (USD Million)
Table 180 South Korea: Third-Party Controls Market, by Type, 2019-2026 (USD Million)
Table 181 South Korea: IVD Quality Control Market, by End User, 2019-2026 (USD Million)
10.4.6 Rest of Asia Pacific
Table 182 RoAPAC: IVD Quality Control Market, by Product & Service, 2019-2026 (USD Million)
Table 183 RoAPAC: IVD Quality Control Products Market, by Type, 2019-2026 (USD Million)
Table 184 RoAPAC: IVD Quality Control Market, by Technology, 2019-2026 (USD Million)
Table 185 RoAPAC: IVD Quality Control Market, by Manufacturer, 2019-2026 (USD Million)
Table 186 RoAPAC: Third-Party Controls Market, by Type, 2019-2026 (USD Million)
Table 187 RoAPAC: IVD Quality Control Market, by End User, 2019-2026 (USD Million)
10.5 Latin America
Table 188 Latin America: IVD Quality Control Market, by Country, 2019-2026 (USD Million)
Table 189 Latin America: IVD Quality Control Market, by Product & Service, 2019-2026 (USD Million)
Table 190 Latin America: IVD Quality Control Products Market, by Type, 2019-2026 (USD Million)
Table 191 Latin America: IVD Quality Control Market, by Technology, 2019-2026 (USD Million)
Table 192 Latin America: IVD Quality Control Market, by Manufacturer, 2019-2026 (USD Million)
Table 193 Latin America: Third-Party Controls Market, by Type, 2019-2026 (USD Million)
Table 194 Latin America: IVD Quality Control Market, by End User, 2019-2026 (USD Million)
10.5.1 Brazil
10.5.1.1 Brazil dominates the Latin American IVD quality control market
Table 195 Brazil: Key Macroindicators
Table 196 Brazil: IVD Quality Control Market, by Product & Service, 2019-2026 (USD Million)
Table 197 Brazil: IVD Quality Control Products Market, by Type, 2019-2026 (USD Million)
Table 198 Brazil: IVD Quality Control Market, by Technology, 2019-2026 (USD Million)
Table 199 Brazil: IVD Quality Control Market, by Manufacturer, 2019-2026 (USD Million)
Table 200 Brazil: Third-Party Controls Market, by Type, 2019-2026 (USD Million)
Table 201 Brazil: IVD Quality Control Market, by End User, 2019-2026 (USD Million)
10.5.2 Mexico
10.5.2.1 Mexico is emerging as a prominent medical tourism hub
Table 202 Mexico: Key Macroindicators
Table 203 Mexico: IVD Quality Control Market, by Product & Service, 2019-2026 (USD Million)
Table 204 Mexico: IVD Quality Control Products Market, by Type, 2019-2026 (USD Million)
Table 205 Mexico: IVD Quality Control Market, by Technology, 2019-2026 (USD Million)
Table 206 Mexico: IVD Quality Control Market, by Manufacturer, 2019-2026 (USD Million)
Table 207 Mexico: Third-Party Controls Market, by Type, 2019-2026 (USD Million)
Table 208 Mexico: IVD Quality Control Market, by End User, 2019-2026 (USD Million)
10.5.3 Rest of Latin America
Table 209 ROLA: IVD Quality Control Market, by Product & Service, 2019-2026 (USD Million)
Table 210 ROLA: IVD Quality Control Products Market, by Type, 2019-2026 (USD Million)
Table 211 ROLA: IVD Quality Control Market, by Technology, 2019-2026 (USD Million)
Table 212 ROLA: IVD Quality Control Market, by Manufacturer, 2019-2026 (USD Million)
Table 213 ROLA: Third-Party Controls Market, by Type, 2019-2026 (USD Million)
Table 214 ROLA: IVD Quality Control Market, by End User, 2019-2026 (USD Million)
10.6 Middle East & Africa
10.6.1 Rising Cancer Incidence Has Attracted Stakeholder Attention To Regional Markets In MEA
Table 215 Middle East & Africa: IVD Quality Control Market, by Product & Service, 2019-2026 (USD Million)
Table 216 Middle East & Africa: IVD Quality Control Products Market, by Type, 2019-2026 (USD Million)
Table 217 Middle East & Africa: IVD Quality Control Market, by Technology, 2019-2026 (USD Million)
Table 218 Middle East & Africa: IVD Quality Control Market, by Manufacturer, 2019-2026 (USD Million)
Table 219 Middle East & Africa: Third-Party Controls Market, by Type, 2019-2026 (USD Million)
Table 220 Middle East & Africa: IVD Quality Control Market, by End User, 2019-2026 (USD Million)

11 Competitive Landscape
11.1 Overview
11.2 Key Player Strategies
11.3 Revenue Share Analysis of the Top Market Players
Figure 40 Revenue Analysis of the Top Players In the IVD Quality Control Market
11.4 Market Share Analysis
Figure 41 IVD Quality Control Market Share, by Key Player, 2020
11.5 Company Evaluation Quadrant
11.5.1 Stars
11.5.2 Emerging Leaders
11.5.3 Pervasive Players
11.5.4 Participants
Figure 42 IVD Quality Control Market: Company Evaluation Quadrant (2020)
11.6 R&D Expenditure
Figure 43 IVD Quality Control Market: R&D Expenditure (In USD Million), 2020
11.7 Company Evaluation Quadrant for Start-Ups
11.7.1 Progressive Companies
11.7.2 Dynamic Companies
11.7.3 Starting Blocks
11.7.4 Responsive Companies
Figure 44 IVD Quality Control Market: Company Evaluation Quadrant for Start-Ups (2020)
11.8 Company Product Footprint
Table 221 Product Portfolio Analysis: IVD Quality Control Market
Figure 45 Technology Portfolio Analysis: IVD Quality Control Market
Table 222 Manufacturer Type Portfolio Analysis: IVD Quality Control Market
Table 223 End-User Portfolio Analysis: IVD Quality Control Market
11.9 Geographic Footprint of the Major Players In the IVD Quality Control Market
Table 224 Geographic Revenue Mix: IVD Quality Control Market (2020)
11.10 Competitive Scenario
11.10.1 Product Launches
Table 225 Product Launches
11.10.2 Deals
Table 226 Deals
11.10.3 Other Developments
Table 227 Other Developments

12 Company Profiles
12.1 Key Players
(Business overview, Products and Services offered, Recent developments, Swot analysis, Mnm view)*
12.1.1 Bio-Rad Laboratories, Inc.
Table 228 Bio-Rad Laboratories, Inc.: Business Overview
Figure 46 Bio-Rad Laboratories, Inc.: Company Snapshot (2020)
12.1.2 Thermo Fisher Scientific, Inc.
Table 229 Thermo Fisher Scientific, Inc.: Business Overview
Figure 47 Thermo Fisher Scientific, Inc.: Company Snapshot
12.1.3 Randox Laboratories Ltd.
Table 230 Randox Laboratories: Business Overview
12.1.4 LGC Limited
Table 231 LGC Limited: Business Overview
Figure 48 LGC Limited: Company Snapshot
12.1.5 Roche Diagnostics
Table 232 F. Hoffmann-La Roche Ag: Business Overview
Figure 49 Roche Diagnostics: Company Snapshot (2020)
12.1.6 Abbott Laboratories
Table 233 Abbott Laboratories: Business Overview
Figure 50 Abbott Laboratories: Company Snapshot (2020)
12.1.7 Siemens Healthineers
Table 234 Siemens Healthineers: Business Overview
Figure 51 Siemens Healthineers: Company Snapshot (2020)
12.1.8 Quidel Corporation
Table 235 Quidel Corporation: Business Overview
Figure 52 Quidel Corporation: Company Snapshot (2020)
12.1.9 Danaher Corporation
Table 236 Danaher Corporation: Business Overview
Figure 53 Danaher Corporation: Company Snapshot (2020)
12.1.10 Sysmex Corporation
Table 237 Sysmex Corporation: Business Overview
Figure 54 Sysmex Corporation: Company Snapshot (2020)
12.1.11 Ortho Clinical Diagnostics
Table 238 Ortho Clinical Diagnostics: Business Overview
Figure 55 Ortho Clinical Diagnostics Holdings Plc: Company Snapshot (2020)
12.1.12 Bio-Techne Corporation
Table 239 Bio-Techne Corporation: Business Overview
Figure 56 Bio-Techne Corporation: Company Snapshot (2020)
12.1.13 Seegene Inc.
Table 240 Seegene Inc.: Business Overview
Figure 57 Seegene Inc: Company Snapshot (2020)
12.1.14 Qnostics
Table 241 Qnostics: Business Overview
12.1.15 Microbiologics, Inc.
Table 242 Microbiologics: Business Overview
12.1.16 Zeptometrix Corporation
Table 243 Zeptometrix Corporation: Business Overview
12.1.17 Fortress Diagnostics
Table 244 Fortress Diagnostics: Business Overview
12.1.18 Microbix Biosystems Inc.
Table 245 Microbix Biosystems: Business Overview
Figure 58 Microbix Biosystems: Company Snapshot
12.1.19 Grifols, S.A.
Table 246 Grifols, S.A.: Business Overview
Figure 59 Grifols, S.A.: Company Snapshot
12.1.20 Alpha-Tec Systems, Inc.
Table 247 Alpha-Tec Systems, Inc.: Business Overview
12.2 Other Players
12.2.1 Helena Laboratories Corporation
Table 248 Helena Laboratories Corporation: Business Overview
12.2.2 Streck, Inc.
Table 249 Streck: Business Overview
12.2.3 Maine Molecular Quality Controls, Inc. (MMQCI)
Table 250 Maine Molecular Quality Controls, Inc.: Business Overview
12.2.4 Sun Diagnostics, Llc
Table 251 Sun Diagnostics, Llc: Business Overview
12.2.5 Sero AS
Table 252 Sero AS: Business Overview

*Business overview, Products and Services offered, Recent developments, Swot analysis, Mnm view might not be captured in case of unlisted companies.

13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: The Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details

Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Alpha-Tec Systems, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Danaher Corporation
  • Fortress Diagnostics
  • Grifols, S.A.
  • Helena Laboratories Corporation
  • LGC Limited
  • Maine Molecular Quality Controls, Inc. (MMQCI)
  • Microbiologics, Inc.
  • Microbix Biosystems Inc.
  • Ortho Clinical Diagnostics
  • Qnostics
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • Roche Diagnostics
  • Seegene Inc.
  • Sero AS
  • Siemens Healthineers
  • Streck, Inc.
  • Sun Diagnostics, Llc
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Zeptometrix Corporation
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll